DK3270950T3 - Isolerede peptider og fragmenter deraf fra fibrinogen til anvendelse som lægemidler, især ved inflammatoriske hudsygdomme - Google Patents
Isolerede peptider og fragmenter deraf fra fibrinogen til anvendelse som lægemidler, især ved inflammatoriske hudsygdomme Download PDFInfo
- Publication number
- DK3270950T3 DK3270950T3 DK16713796.7T DK16713796T DK3270950T3 DK 3270950 T3 DK3270950 T3 DK 3270950T3 DK 16713796 T DK16713796 T DK 16713796T DK 3270950 T3 DK3270950 T3 DK 3270950T3
- Authority
- DK
- Denmark
- Prior art keywords
- fibrinogen
- fragments
- skin diseases
- inflammatory skin
- medicinal products
- Prior art date
Links
- 201000004624 Dermatitis Diseases 0.000 title 1
- 102000008946 Fibrinogen Human genes 0.000 title 1
- 108010049003 Fibrinogen Proteins 0.000 title 1
- 229940012952 fibrinogen Drugs 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305414 | 2015-03-20 | ||
| PCT/EP2016/056179 WO2016150926A1 (en) | 2015-03-20 | 2016-03-21 | Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3270950T3 true DK3270950T3 (da) | 2021-06-07 |
Family
ID=52807757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16713796.7T DK3270950T3 (da) | 2015-03-20 | 2016-03-21 | Isolerede peptider og fragmenter deraf fra fibrinogen til anvendelse som lægemidler, især ved inflammatoriske hudsygdomme |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10323078B2 (enExample) |
| EP (1) | EP3270950B1 (enExample) |
| JP (1) | JP6840086B2 (enExample) |
| CN (1) | CN107636011B (enExample) |
| AU (1) | AU2016236297B2 (enExample) |
| BR (1) | BR112017020008A8 (enExample) |
| CA (1) | CA2979812C (enExample) |
| DK (1) | DK3270950T3 (enExample) |
| ES (1) | ES2880795T3 (enExample) |
| WO (1) | WO2016150926A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12502424B2 (en) | 2023-05-05 | 2025-12-23 | Sanofi Pasteur Inc. | Compositions for use in treatment of acne |
| CN117304303B (zh) * | 2023-07-14 | 2024-07-05 | 杭州恩和生物科技有限公司 | 纤连蛋白截短片段、组合物及用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2032527C (en) * | 1989-04-10 | 2002-07-02 | Jesse M. Jaynes | Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth |
| US5639940A (en) * | 1994-03-03 | 1997-06-17 | Pharmaceutical Proteins Ltd. | Production of fibrinogen in transgenic animals |
| US6783961B1 (en) * | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| WO2001001150A2 (en) * | 1999-06-30 | 2001-01-04 | Regents Of The University Of California | Diagnostic test for thrombotic or thromboembolic disease |
| CA2453202C (en) * | 2001-07-06 | 2012-10-16 | Oregon Health & Science University | Peptides which modulate blood coagulation and methods of use thereof |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| AU2004232487A1 (en) * | 2003-04-23 | 2004-11-04 | Hansa Medical Ab | Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections |
| US7807409B2 (en) * | 2005-10-21 | 2010-10-05 | Roche Palo Alto Llc | Method for the recombinant expression of a polypeptide |
| US20130280820A1 (en) * | 2005-12-16 | 2013-10-24 | Schering Corporation | Biomarkers for psoriasis |
| NZ574653A (en) * | 2006-08-04 | 2012-11-30 | Stb Lifesaving Technologies Inc | Solid dressing for treating wounded tissue |
| WO2008116468A2 (en) * | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
| CN101618211A (zh) * | 2008-07-03 | 2010-01-06 | 珠海联邦制药股份有限公司 | 一种乙肝多肽疫苗及其应用 |
| US20110177524A1 (en) * | 2008-07-09 | 2011-07-21 | Profibrix Bv | Recombinant Fibrinogen |
| US20120052066A1 (en) * | 2008-11-07 | 2012-03-01 | Cesar Calderon | Markers and methods for assessing and treating lupus patients susceptible to photoprovocation |
| EP4012714A1 (en) * | 2010-03-23 | 2022-06-15 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| CA2825765C (en) * | 2011-02-02 | 2020-03-10 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Anti-carbamylated protein antibodies and the risk for arthritis |
-
2016
- 2016-03-21 DK DK16713796.7T patent/DK3270950T3/da active
- 2016-03-21 EP EP16713796.7A patent/EP3270950B1/en active Active
- 2016-03-21 BR BR112017020008A patent/BR112017020008A8/pt not_active IP Right Cessation
- 2016-03-21 CA CA2979812A patent/CA2979812C/en active Active
- 2016-03-21 JP JP2017549280A patent/JP6840086B2/ja active Active
- 2016-03-21 US US15/559,984 patent/US10323078B2/en active Active
- 2016-03-21 ES ES16713796T patent/ES2880795T3/es active Active
- 2016-03-21 WO PCT/EP2016/056179 patent/WO2016150926A1/en not_active Ceased
- 2016-03-21 AU AU2016236297A patent/AU2016236297B2/en active Active
- 2016-03-21 CN CN201680026130.XA patent/CN107636011B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2979812C (en) | 2023-08-29 |
| JP6840086B2 (ja) | 2021-03-10 |
| JP2018512844A (ja) | 2018-05-24 |
| EP3270950B1 (en) | 2021-04-21 |
| AU2016236297B2 (en) | 2020-07-23 |
| US20180105574A1 (en) | 2018-04-19 |
| WO2016150926A1 (en) | 2016-09-29 |
| CN107636011A (zh) | 2018-01-26 |
| AU2016236297A1 (en) | 2017-09-28 |
| CA2979812A1 (en) | 2016-09-29 |
| EP3270950A1 (en) | 2018-01-24 |
| US10323078B2 (en) | 2019-06-18 |
| ES2880795T3 (es) | 2021-11-25 |
| BR112017020008A2 (pt) | 2018-06-19 |
| CN107636011B (zh) | 2021-07-02 |
| BR112017020008A8 (pt) | 2023-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290823A (en) | Pharmaceutical compositions for combination therapy | |
| DK3274321T3 (da) | Cannabidiol-isolat fra industriel hamp og anvendelse deraf i farmaceutiske og/eller kosmetiske præparater | |
| IL256085B (en) | A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment | |
| DK3643709T3 (da) | Isoindolinderivat, mellemprodukt, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf | |
| DK3209681T3 (da) | Farmaceutiske sammensætninger omfattende peptidvarianter og fremgangsmåder til anvendelse deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| HUE057726T2 (hu) | Fehérje glikozilálására szolgáló készítmények és módszerek | |
| BR112016018062A2 (pt) | compostos terapêuticos, composição farmacêutica e usos | |
| EP3238736A4 (en) | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same | |
| DK3233111T3 (da) | Farmaceutisk sammensætning, der omfatter plasminogen, og anvendelser deraf | |
| BR112016027595A2 (pt) | Produtos de peptídeos, composição farmacêutica compreendendo um produto de peptídeo, uso de um produto de peptídeo e método para produzir um produto de peptídeo | |
| EP3148575A4 (en) | Methods and compositions for treating allergy and inflammatory diseases | |
| DK3348260T3 (da) | Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse | |
| DK3608334T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formuleringer og anvendelse deraf | |
| ZA201607729B (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| HUE055515T2 (hu) | Bioaktív fehérje, alkalmazása és eljárás elõállítására | |
| DK3236934T3 (da) | Farmaceutisk sammensætning, fremstilling og anvendelser deraf | |
| DK3383397T3 (da) | Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin | |
| EP3190129A4 (en) | Centrally-acting peptide derivative, and pharmaceutical composition | |
| GB2546439B (en) | Ezrin-derived peptides and pharmaceutical compositions thereof | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| DK3129057T3 (da) | Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi | |
| EP3399990A4 (en) | THERAPEUTIC COMPOSITIONS WITH PEPTIDES AND USES THEREOF | |
| DK3120852T3 (da) | Præventivt og/eller terapeutisk middel til immunsygdomme | |
| DK3270950T3 (da) | Isolerede peptider og fragmenter deraf fra fibrinogen til anvendelse som lægemidler, især ved inflammatoriske hudsygdomme |